Detalhe da pesquisa
1.
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.
Int J Mol Sci
; 25(6)2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542177
2.
T1AM/TAAR1 System Reduces Inflammatory Response and ß-Amyloid Toxicity in Human Microglial HMC3 Cell Line.
Int J Mol Sci
; 24(14)2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511328
3.
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.
Int J Mol Sci
; 24(3)2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768458
4.
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism.
J Pers Med
; 14(2)2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38392648
5.
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by ß-Amyloid in Glial Cells.
Cells
; 13(10)2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38786097
6.
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease.
J Clin Med
; 12(23)2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38068253
7.
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R).
Front Chem
; 10: 984069, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238097
8.
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.
J Med Chem
; 65(14): 9918-9938, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849804